Quality metrics for resection: Are they reasonable?

Size: px
Start display at page:

Download "Quality metrics for resection: Are they reasonable?"

Transcription

1 Quality metrics for resection: Are they reasonable? G. Alexander Patterson, MD Joseph C. Bancroft Professor of Surgery Division of Cardiothoracic Surgery Editor, Annals of Thoracic Surgery

2 History of Outcomes Research & Public Reporting The trustees of hospitals should see to it that an effort is made to follow up each patient they treat, long enough to determine whether the treatment given has permanently relieved the condition or symptoms complained of. Dr. Ernest Amory Codman, 1918

3 TO ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM Institute of Medicine National Academy Press Public Reporting Pay for Performance Safety - Quality

4 Quality - Alphabet Soup

5 Standardization 36 International General Thoracic Surgeons Evidence Based

6 Global Outcomes for Lung Cancer International Consortium for Health Outcome Measurement Multi-disciplinary working group International consensus outcomes Case mix variables Survival, complications, patient reported domains (pain, fatigue, cough, dyspnea) Mak KS et al. Eur Resp J. 2016

7 Variance in Management of Stage IIIA (N2) Trans-Atlantic perspective that surgery should play a role in selected IIIA patients North America More likely to stage the mediastinum pre-op Less likely to offer surgery when N2 is identified pre-op More likely to use induction Rx Europe More likely to perform a more extensive lymph node dissection Rocco G et al. Annals Thor Surg 2016; 101:

8 Voluntary STS - GTSDB Provides participants with risk-adjusted semiannual performance reports that allow comparison of institutional outcomes against national benchmarks 1000 surgeons contributing data from over 300 centers 500,000 patients

9 GTSDB 2016 Updated risk models for lung resection and esophagectomy for cancer were reported Composite quality measures for lobectomy and esophagectomy were developed

10 GTSDB 2017 Upgrading the STS GTSD Establishing public reporting of lobectomy for lung cancer composite scores Creating an on-line dashboard Strengthening international collaboration with the European Society of Thoracic Surgery Registry

11 Performance measures ACSD..CABG, AVR, AVR+CABG GTSDB 2016 Lobectomy for lung cancer 20,657 patients were examined who underwent lobectomy at 231 institutions between 2011 and outcomes Risk-adjusted mortality Risk-adjusted major complications (any or none)

12 Ann Thorac Surg 2016;101: by The Society of Thoracic Surgeons

13 STS Composite Score for Rating Program Performance for Lobectomy Risk-adjusted mortality and major complication rates varied 3-fold from highest performing (3 star) to lowest performing (1 star) programs. 3 star (7%), 2 star (88%), 1 star (5%) 25% had insufficient volume (n=30: ) to permit star rating Kozower BD et al. Annals Thor Surg 2016; 101:

14 STS Updated Risk Models Logistic regression; 3 risk models for adverse events following resection Operative mortality, major morbidity, composite mortality and major morbidity 27,844 resections, 231 centers Fernandez FG et al. Ann Thor Surg 2016; 102:370-7.

15 STS Updated Risk Models Mortality 1.4%; morbidity 9.1% Predictors of mortality; age, male, FEV 1, BMI, cerebrovascular disease, steroids, CAD, PVD, renal dysfunction, Zubrod score, ASA rating, thoracotomy, induction Rx, reoperation, tumor stage, extent of resection (p<0.05 for all) Fernandez FG et al. Ann Thor Surg 2016; 102:370-7.

16 STS National Database Weaknesses Voluntary Expensive, $$ and personnel Multiple data fields 30 day follow-up

17 Longitudinal Follow-up in Older Patients Link STS database to Centers for Medicare and Medicaid Services (CMS) Medicare/Medicaid patient over age 65 26,055 patients Median survival for pathologic Stage yrs; Stage II-3.5 yrs; Stage III-2.4 yrs; Stage IV-2.2 yrs. Fernandez, FG et al. Annals Thor Surg 2016; 101: 2067

18 Failure to Rescue Important concept and possible measure of quality Variation in hospital mortality seems to be more strongly related to rescuing patients from complications than to the occurrence of complications. Farjah F et al. JTCVS 2015; 149: Kozower BD et al. JTCVS 2015; 149:

19 Ann Thorac Surg 2009;88: ATS 2009;88:1393

20 Quality Metrics NQF Endorsed Measures STS measures for GTS (lung cancer) Participation in a systematic national database Preoperative recording of clinical stage Preoperative recording of performance status Risk-adjusted morbidity Length of stay >14 days following lobectomy Risk adjusted morbidity and mortality for resection Seder CW et al. Annals Thor Surg 2016; 101:

STS General Thoracic Surgery Database (GTSD) Update

STS General Thoracic Surgery Database (GTSD) Update STS General Thoracic Surgery Database (GTSD) Update Benjamin D. Kozower, MD, MPH Professor of Surgery Chair, STS GTSD Co-Director, Surgical Outcomes Research Center Washington University St. Louis, MO

More information

The STS Database is the Best Measure of Quality: CON

The STS Database is the Best Measure of Quality: CON The STS Database is the Best Measure of Quality: CON Inderpal (Netu) S. Sarkaria, MD, FACS Vice Chairman, Clinical Affairs Director, Robotic Thoracic Surgery Co-Director, Esophageal and Lung Surgery Institute

More information

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard

Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard AATS General Thoracic Surgery Symposium May 5, 2010 Thomas A. D Amico MD Professor of Surgery, Duke University Medical

More information

T3 NSCLC: Chest Wall, Diaphragm, Mediastinum

T3 NSCLC: Chest Wall, Diaphragm, Mediastinum for T3 NSCLC: Chest Wall, Diaphragm, Mediastinum AATS Postgraduate Course April 29, 2012 Thomas A. D Amico MD Professor of Surgery, Chief of Thoracic Surgery Duke University Health System Disclosure No

More information

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University Disclosures I have no conflict of interest disclosures

More information

ORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery

ORIGINAL PAPER. Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Nagoya J. Med. Sci. 79. 37 ~ 42, 2017 doi:10.18999/nagjms.79.1.37 ORIGINAL PAPER Marginal pulmonary function is associated with poor short- and long-term outcomes in lung cancer surgery Naoki Ozeki, Koji

More information

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,

More information

Thoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014

Thoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014 for Locally Advanced Lung Cancer Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014 Thomas A. D Amico MD Gary Hock Endowed Professor and Vice Chair of Surgery Chief Thoracic Surgery

More information

Lung Cancer Resection on Cardiopulmonary Bypass. Daniel J. Boffa, MD Yale University

Lung Cancer Resection on Cardiopulmonary Bypass. Daniel J. Boffa, MD Yale University Lung Cancer Resection on Cardiopulmonary Bypass Daniel J. Boffa, MD Yale University None related to talk Disclosures Disclaimers I love operating on CPB Disclaimers I love operating on CPB I avoid it for

More information

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty A Review of ACS-NSQIP 2006-2012 Arjun Sebastian, M.D., Stephanie Polites, M.D., Kristine Thomsen, B.S., Elizabeth Habermann,

More information

Pneumonectomy After Induction Rx: Is it Safe?

Pneumonectomy After Induction Rx: Is it Safe? Pneumonectomy After Induction Rx: Is it Safe? David J. Sugarbaker, M.D. Director, Chief, Division of Thoracic Surgery The Olga Keith Weiss Chair of Surgery of Medicine at, Pneumonectomy after induction

More information

STS National Database

STS National Database STS National Database The U.S. Agency for Healthcare Research and Quality (AHRQ) Learning Network for Chartered Value Exchanges (CVEs) Webinar: Using Registries for Health Care Quality Measurement Thursday,

More information

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD

Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery WVU Heart and Vascular Institute

More information

VATS after induction therapy: Effective and Beneficial Tips on Strategy

VATS after induction therapy: Effective and Beneficial Tips on Strategy VATS after induction therapy: Effective and Beneficial Tips on Strategy AATS Focus on Thoracic Surgery Mastering Surgical Innovation Las Vegas Nevada Oct. 27-28 2017 Scott J. Swanson, M.D. Professor of

More information

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?

Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed

More information

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,

More information

Surgical Approaches to Pulmonary Metastases

Surgical Approaches to Pulmonary Metastases Surgical Approaches to Pulmonary Metastases Raja M Flores MD Professor and Chief Thoracic Surgery Mount Sinai School of Medicine New York, New York History of Lung Metastasectomy 1882 Weinlechner +CW 1926

More information

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand?

MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand? MINIMALLY INVASIVE ESOPHAGECTOMY FOR CANCER: where do we stand? Ph Nafteux, MD Copenhagen, Nov 3rd 2011 Department of Thoracic Surgery, University Hospitals Leuven, Belgium W. Coosemans, H. Decaluwé, Ph.

More information

Disclosures. Preoperative Treatment: Chemotherapy or ChemoRT? Adjuvant chemotherapy helps. so what about chemo first?

Disclosures. Preoperative Treatment: Chemotherapy or ChemoRT? Adjuvant chemotherapy helps. so what about chemo first? Disclosures Preoperative Treatment: Chemotherapy or ChemoRT? Advisory boards Genentech (travel only), Pfizer Salary support for clinical trials Celgene, Merck, Merrimack Matthew Gubens, MD, MS Assistant

More information

The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes

The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes The Society of Thoracic Surgeons General Thoracic Surgery Database: Establishing Generalizability to National Lung Cancer Resection Outcomes Damien J. LaPar, MD, MS, Castigliano M. Bhamidipati, DO, MS,

More information

Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital

Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled

More information

Impact of Tidal Volume on Complications after Thoracic Surgery

Impact of Tidal Volume on Complications after Thoracic Surgery Management of One-lung Ventilation Impact of Tidal Volume on Complications after Thoracic Surgery ABSTRACT Background: The use of lung-protective ventilation (LPV) strategies may minimize iatrogenic lung

More information

Tools, Reports, and Resources

Tools, Reports, and Resources Tools, Reports, and Resources What the National Cancer Database (NCDB) does for CoC-Accredited Programs By using the NCDB, CoC-accredited programs can proactively improve delivery and quality of care for

More information

Sagar Damle, MD University of Colorado Denver May 23, 2011

Sagar Damle, MD University of Colorado Denver May 23, 2011 Sagar Damle, MD University of Colorado Denver May 23, 2011 We have debated many times. Here are the topics, and a recap of the last few Pre-operative nutrition Babu pro; Damle con Utility of ECMO Babu

More information

THE NATIONAL QUALITY FORUM

THE NATIONAL QUALITY FORUM THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use

More information

The Pennsylvania State University. The Graduate School. Department of Public Health Sciences

The Pennsylvania State University. The Graduate School. Department of Public Health Sciences The Pennsylvania State University The Graduate School Department of Public Health Sciences THE LENGTH OF STAY AND READMISSIONS IN MASTECTOMY PATIENTS A Thesis in Public Health Sciences by Susie Sun 2015

More information

The Itracacies of Staging Patients with Suspected Lung Cancer

The Itracacies of Staging Patients with Suspected Lung Cancer The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung

More information

Ashleigh Clark 1, Jessica Ozdirik 2, Christopher Cao 1,2. Introduction

Ashleigh Clark 1, Jessica Ozdirik 2, Christopher Cao 1,2. Introduction Review Article Page 1 of 5 Thoracotomy, video-assisted thoracoscopic surgery and robotic video-assisted thoracoscopic surgery: does literature provide an argument for any approach? Ashleigh Clark 1, Jessica

More information

J Clin Oncol by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol by American Society of Clinical Oncology INTRODUCTION JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Minimally Invasive Lung Cancer Surgery Performed by Thoracic Surgeons as Effective as Thoracotomy Daniel J. Boffa, Andrzej S. Kosinski, Anthony

More information

The right middle lobe is the smallest lobe in the lung, and

The right middle lobe is the smallest lobe in the lung, and ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,

More information

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents

Surgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at

More information

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

Below is summarised some of the tools and papers that are worth looking at if you have an interest in the area.

Below is summarised some of the tools and papers that are worth looking at if you have an interest in the area. What happens to the high risk patients who don t die? Perioperative SIG meeting PBLD Noosa 2015 Nicola Broadbent, Auckland, NZ In the process of writing this problem based learning discussion I have read

More information

Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia

Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties

More information

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu

More information

Lung Cancer in Octogenarians: Factors Affecting Morbidity and Mortality After Pulmonary Resection

Lung Cancer in Octogenarians: Factors Affecting Morbidity and Mortality After Pulmonary Resection ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS

More information

Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function

Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function Kneuertz et al. Journal of Cardiothoracic Surgery (2018) 13:56 https://doi.org/10.1186/s13019-018-0748-z RESEARCH ARTICLE Open Access Robotic lobectomy has the greatest benefit in patients with marginal

More information

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

Modeling major lung resection outcomes using classification trees and multiple imputation techniques

Modeling major lung resection outcomes using classification trees and multiple imputation techniques European Journal of Cardio-thoracic Surgery 34 (2008) 1085 1089 www.elsevier.com/locate/ejcts Modeling major lung resection outcomes using classification trees and multiple imputation techniques Mark K.

More information

ROBOT SURGEY AND MINIMALLY INVASIVE TREATMENT FOR LUNG CANCER

ROBOT SURGEY AND MINIMALLY INVASIVE TREATMENT FOR LUNG CANCER ROBOT SURGEY AND MINIMALLY INVASIVE TREATMENT FOR LUNG CANCER Giulia Veronesi European Institute of Oncology Milan Lucerne, Samo 24 th - 25 th January, 2014 DIAGNOSTIC REVOLUTION FOR LUNG CANCER - Imaging

More information

Minimally Invasive Esophagectomy

Minimally Invasive Esophagectomy Minimally Invasive Esophagectomy M A R K B E R R Y, M D A S S O C I AT E P R O F E S S O R D E PA R T M E N T OF C A R D I O T H O R A C I C S U R G E R Y S TA N F O R D U N I V E R S I T Y S E P T E M

More information

Variability in length of stay after uncomplicated pulmonary lobectomy: is length of stay a quality metric or a patient metric?

Variability in length of stay after uncomplicated pulmonary lobectomy: is length of stay a quality metric or a patient metric? European Journal of Cardio-Thoracic Surgery 49 (2016) e65 e71 doi:10.1093/ejcts/ezv476 Advance Access publication 27 January 2016 ORIGINAL ARTICLE Cite this article as: Giambrone GP, Smith MC, Wu X, Gaber-Baylis

More information

Washington State Spine Surgery

Washington State Spine Surgery Washington State Spine Surgery Spine SCOAP Statistics and Key Findings, 2015-2017 Arman Dagal, MD, FRCA Spine SCOAP Medical Director Ian Painter, PhD SCOAP Biostatistician Vickie Kolios-Morris, MSHSA,

More information

History of Surgery for Lung Cancer

History of Surgery for Lung Cancer Welcome to Master Class for Oncologists Session 1: 7:30 AM - 8:15 AM San Francisco, CA October 23, 2009 Innovations in The Surgical Treatment of Lung Cancer Speaker: Scott J. Swanson, MD 2 Presenter Disclosure

More information

Newly Diagnosed Cases Cancer Related Death NCI 2006 Data

Newly Diagnosed Cases Cancer Related Death NCI 2006 Data Multi-Disciplinary Management of Esophageal Cancer: Surgical and Medical Steps Forward Alarming Thoracic Twin Towers 200000 150000 UCSF UCD Thoracic Oncology Conference November 21, 2009 100000 50000 0

More information

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards

More information

Reducing lung volume in emphysema Surgical Aspects

Reducing lung volume in emphysema Surgical Aspects Reducing lung volume in emphysema Surgical Aspects Simon Jordan Consultant Thoracic Surgeon Royal Brompton Hospital Thirteenth Cambridge Chest Meeting April 2015 Surgical aspects of LVR Why we should NOT

More information

NSQIP-P for the comparative analysis of resource utilization and disease-specific outcomes:

NSQIP-P for the comparative analysis of resource utilization and disease-specific outcomes: NSQIP-P for the comparative analysis of resource utilization and disease-specific outcomes: Implications for Benchmarking and Collaborative Quality Improvement Shawn J. Rangel, MD, MSCE ACS NSQIP Conference

More information

procedures for severe Aortic stenosis Treatment

procedures for severe Aortic stenosis Treatment Italian OBservational Study of Effectiveness of AVR TAVI procedures for severe Aortic stenosis Treatment Subgroup Analyses Corrado Tamburino SOCIETA' ITALIANA DI CHIRURGIA CARDIACA onlus ITACTA ITALIAN

More information

STAGE I INOPERABLE NSCLC RADIOFREQUENCY ABLATION OR STEREOTACTIC BODY RADIOTHERAPY?

STAGE I INOPERABLE NSCLC RADIOFREQUENCY ABLATION OR STEREOTACTIC BODY RADIOTHERAPY? STAGE I INOPERABLE NSCLC RADIOFREQUENCY ABLATION OR STEREOTACTIC BODY RADIOTHERAPY? MICHAEL LANUTI, MD American Association of Thoracic Surgeons Minneapolis, MN 2013 STAGE I INOPERABLE NSCLC RADIOFREQUENCY

More information

J. MAXWELL CHAMBERLAIN MEMORIAL PAPER FOR GENERAL THORACIC SURGERY

J. MAXWELL CHAMBERLAIN MEMORIAL PAPER FOR GENERAL THORACIC SURGERY J. MAXWELL CHAMBERLAIN MEMORIAL PAPER FOR SURGERY STS Database Risk Models: Predictors of Mortality and Major Morbidity for Lung Cancer Resection Benjamin D. Kozower, MD, MPH, Shubin Sheng, PhD, Sean M.

More information

Parenchymal air leak is a frequent complication after. Pleural Tent After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect

Parenchymal air leak is a frequent complication after. Pleural Tent After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect Pleural After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect Alessandro Brunelli, MD, Majed Al Refai, MD, Marco Monteverde, MD, Alessandro Borri, MD, Michele Salati, MD, Armando

More information

Utility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC)

Utility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC) Utility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC) Poster No.: C-1360 Congress: ECR 2015 Type: Scientific Exhibit Authors:

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer

Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer Post-Induction PET Does Not Correlate with Persistent Nodal Disease or Overall Survival in Surgically Treated Stage IIIA Non-Small Cell Lung Cancer R. Taylor Ripley, Kei Suzuki, Kay See Tan, Manjit Bains,

More information

TAAA / Spinal Cord Protection

TAAA / Spinal Cord Protection TAAA / Spinal Cord Protection Hazim J. Safi, MD Professor and Chair Department of Cardiothoracic and Vascular Surgery McGovern Medical School The University of Texas Science Center at Houston Memorial

More information

Is Resection Superior to SBRT for Stage I Lesions. Traves Crabtree MD Professor of Surgery Southern Illinois University School of Medicine

Is Resection Superior to SBRT for Stage I Lesions. Traves Crabtree MD Professor of Surgery Southern Illinois University School of Medicine Is Resection Superior to SBRT for Stage I Lesions Traves Crabtree MD Professor of Surgery Southern Illinois University School of Medicine I have nothing pertinent to disclose. Patterns of Recurrence for

More information

Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease

Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Tristate Lung Meeting 2014 Pro-Con Debate: Surgery has no role in the management of certain subsets of N2 disease Jennifer E. Tseng, MD UFHealth Cancer Center-Orlando Health Sep 12, 2014 Background Approximately

More information

SOC s Guide to the 2013 CMS New Core Measures for Stroke

SOC s Guide to the 2013 CMS New Core Measures for Stroke SOC s Guide to the 2013 CMS New Core Measures for Stroke Since 2004, the Centers for Medicare & Medicaid Services (CMS) has collected quality data from acute care hospitals on a voluntary basis under the

More information

VATS Metastasectomy. Inderpal (Netu) S. Sarkaria, MD, FACS

VATS Metastasectomy. Inderpal (Netu) S. Sarkaria, MD, FACS VATS Metastasectomy Inderpal (Netu) S. Sarkaria, MD, FACS Vice Chairman, Clinical Affairs Director, Robotic Thoracic Surgery Co-Director, Esophageal and Lung Surgery Institute Disclosures Speaking & Education:

More information

TAVI After PARTNER-2 : The Hamilton Approach

TAVI After PARTNER-2 : The Hamilton Approach TAVI After PARTNER-2 : The Hamilton Approach James L. Velianou MD FRCPC Interventional Cardiology Hamilton General Hospital St Catharines General Hospital Associate Professor of Medicine McMaster University

More information

Cancer Technical Report January 13, 2017

Cancer Technical Report January 13, 2017 Cancer 2015-2017 Technical Report January 13, 2017 This report is funded by the Department of Health and Human Services under contract HHSM-500-2012-00009I Task Order HHSM-500-T0008 1 Contents Executive

More information

Current Issues in Thyroid Cancer Surgery in 2017

Current Issues in Thyroid Cancer Surgery in 2017 Current Issues in Thyroid Cancer Surgery in 2017 Dr. David Goldstein MD Msc FRCSC FACS Associate Professor, Department Otolaryngology Head & Neck Surgery, U of T Department of Surgical Oncology, Princess

More information

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm

More information

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Assistant Professor, Georgetown School of Medicine

More information

Atrial Fibrillation Ablation Thinktank

Atrial Fibrillation Ablation Thinktank Atrial Fibrillation Ablation Thinktank Mitchell J. Magee, M.D. STS National Database Taskforce CRSTI Dallas, TX FDA, Silver Spring, MD April 27, 2009 STS National Database Current Status Update Adult Cardiac

More information

Recent evidence regarding resection rate, specialism and survival in lung cancer in the UK

Recent evidence regarding resection rate, specialism and survival in lung cancer in the UK Recent evidence regarding resection rate, specialism and survival in lung cancer in the UK Dr Mick Peake Glenfield Hospital, Leicester Clinical Lead, National Cancer Intelligence Network & National Lung

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #358: Patient-Centered Surgical Risk Assessment and Communication National Quality Strategy Domain: Person and Caregiver-Centered Experience and Outcomes 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Examination of Hospital-Level Variation in Preventing Post-Operative Sepsis

Examination of Hospital-Level Variation in Preventing Post-Operative Sepsis Examination of Hospital-Level Variation in Preventing Post-Operative Sepsis Elizabeth Berger, MD; Sanjay Mohanty MD MS; Lynn Zhou PhD; Mark Cohen, PhD; Bruce Hall MD PhD MBA; Cliff Ko, MD MS MSHS; Karl

More information

The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement

The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement Georgia Vascular Society Adam W. Beck, MD, FACS September 9, 2017 Disclosures No relevant

More information

Accepted Manuscript. Current State of the Art for the Surgical Management of empyema thoracis. K. Robert Shen, M.D.

Accepted Manuscript. Current State of the Art for the Surgical Management of empyema thoracis. K. Robert Shen, M.D. Accepted Manuscript Current State of the Art for the Surgical Management of empyema thoracis K. Robert Shen, M.D. PII: S0022-5223(18)32919-2 DOI: https://doi.org/10.1016/j.jtcvs.2018.11.006 Reference:

More information

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis

Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD

More information

Intraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty

Intraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty Intraoperative Oncologic Staging and Outcomes for Lung Cancer Resection Vary by Surgeon Specialty Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, and Paul H. Schipper, MD Department of Surgery,

More information

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict

More information

Impact of Preoperative Bowel Preparation on the Risk of Clostridium Difficile after Colorectal Surgery: A Propensity Weighted Analysis

Impact of Preoperative Bowel Preparation on the Risk of Clostridium Difficile after Colorectal Surgery: A Propensity Weighted Analysis Impact of Preoperative Bowel Preparation on the Risk of Clostridium Difficile after Colorectal Surgery: A Propensity Weighted Analysis Ebram Salama, MD PGY-3 General Surgery Sir Mortimer B. Davis Jewish

More information

including prevention, healthy lifestyle behaviors, populations at risk & disparities (age, race/ ethnicity, gender, geographic & socioeconomic)

including prevention, healthy lifestyle behaviors, populations at risk & disparities (age, race/ ethnicity, gender, geographic & socioeconomic) Endorsement Maintenance 2010 Identification of Gap Areas for which Evidence-based Surgery-related Measures are Needed Cardiac, General, Other Surgical Subspecialties The table below is a tool that identifies

More information

Robotic Surgery for Esophageal Cancer

Robotic Surgery for Esophageal Cancer Robotic Surgery for Esophageal Cancer Kemp H. Kernstine, MD PhD Division of Thoracic Surgery City of Hope Medical Center and Beckman Research Institute May 1, 2010 Esophageal Cancer on the Rise JNCI 2005,

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #51 (NQF 0091): Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

What is an Adequate Lumpectomy Margin in 2018?

What is an Adequate Lumpectomy Margin in 2018? What is an Adequate Lumpectomy Margin in 2018? Stuart J. Schnitt, M.D. Brigham and Women s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School Boston, MA None Disclosures Topics Current

More information

11/21/ M with LUL Mass Case Presentation / Round Table Discussion. Multiple-choice question What stage is this tumor?

11/21/ M with LUL Mass Case Presentation / Round Table Discussion. Multiple-choice question What stage is this tumor? MS 62M with LUL Mass Case Presentation / Round Table Discussion Dr. Jasleen Kukreja and Johannes Kratz Department of Thoracic Surgery University of California, San Francisco 62M, presented to clinic 6/2009

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Won EJ, Lehman EB, Geletzke AK, et al. Association of postoperative hyperglycemia with outcomes among patients with complex ventral hernia repair. JAMA Surg. Published online

More information

Thoracoscopic Lobectomy: Technical Aspects in Years of Progress

Thoracoscopic Lobectomy: Technical Aspects in Years of Progress Thoracoscopic Lobectomy: Technical Aspects in 2015 16 Years of Progress 8 th Masters of Minimally Invasive Thoracic Surgery Orlando September 25, 2015 Thomas A. D Amico MD Gary Hock Professor of Surgery

More information

ORIGINAL ARTICLE. Abstract INTRODUCTION

ORIGINAL ARTICLE. Abstract INTRODUCTION European Journal of Cardio-Thoracic Surgery 49 (2016) 1054 1058 doi:10.1093/ejcts/ezv378 Advance Access publication 24 November 2015 ORIGINAL ARTICLE Cite this article as: Begum SSS, Papagiannopoulos K,

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

Postoperative Mortality in Lung Cancer Patients

Postoperative Mortality in Lung Cancer Patients Review Postoperative Mortality in Lung Cancer Patients Kanji Nagai, MD, Junji Yoshida, MD, and Mitsuyo Nishimura, MD Surgery for lung cancer frequently results in serious life-threatening complications,

More information

Red Blood Cell Conservation A Surgeon s Journey. Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital

Red Blood Cell Conservation A Surgeon s Journey. Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital Red Blood Cell Conservation A Surgeon s Journey Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital Red Blood Cell Conservation Clinical impetus Evidence based learning Program development Industry partnerships

More information

Cancer Center Dashboard

Cancer Center Dashboard Cancer Center Dashboard Measure Definition Benchmark Endorsed By Screening Breast Cancer Screening Percentage of eligible women 40-69 who received a mammogram within the past 24 months NCQA reported average:

More information

Leveraging Your Cancer Registry: A Strategy for Survey Success

Leveraging Your Cancer Registry: A Strategy for Survey Success CoC-trained consultants on staff Leveraging Your Cancer Registry: A Strategy for Survey Success Toni Hare, RHIT, CTR CoC-trained Consultant Vice President, CHAMPS Oncology November 27, 2012 Georgia s Best

More information

Registry Highlights. Dale Daniel Symposium Hip Fracture Registry. Overall Volume by Year and Region 3/7/2014

Registry Highlights. Dale Daniel Symposium Hip Fracture Registry. Overall Volume by Year and Region 3/7/2014 Dale Daniel Symposium 2014 Registry Highlights Overview: Updated Volume NCAL/SCAL Snapshot Hip Fracture Registry Update Gary Zohman, MD SCAL Regional Lead Anaheim, CA Quarterly Quality Report Review Future

More information

What is the Role of Surgical Repair in 2012

What is the Role of Surgical Repair in 2012 What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th

More information

Induction chemotherapy followed by surgical resection

Induction chemotherapy followed by surgical resection Surgical Resection for Residual N 2 Disease After Induction Chemotherapy Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Matthew A. Levin, BS, David E. Becker, MA, Roger Keresztes, MD, and Nasser

More information

Stereotactic ablative radiotherapy in early NSCLC and metastases

Stereotactic ablative radiotherapy in early NSCLC and metastases Stereotactic ablative radiotherapy in early NSCLC and metastases Scheduled: 0810-0830 hrs, 10 March 2012 Professor Suresh Senan Department of Radiation Oncology SABR in stage I NSCLC A major treatment

More information

De.3 If included in a composite, please identify the composite measure (title and NQF number if endorsed): n/a

De.3 If included in a composite, please identify the composite measure (title and NQF number if endorsed): n/a NQF #1790 Risk-Adjusted Morbidity and Mortality for Lung Resection for Lung Cancer NATIONAL QUALITY FORUM Measure Submission and Evaluation Worksheet 5.0 This form contains the information submitted by

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, pancreatic ductal, laparoscopic distal pancreatectomy for, 61 Adrenal cortical carcinoma, laparoscopic adrenalectomy for, 114

More information

Making the Most of Your Cancer Registry

Making the Most of Your Cancer Registry www.champsods.com Making the Most of Your Cancer Registry Presenter: Toni Hare, Vice President CHAMPS Oncology Data Services Picture of girl here December 11, 2009 Learning Objectives Upon completion of

More information

Lung Cancer Epidemiology. AJCC Staging 6 th edition

Lung Cancer Epidemiology. AJCC Staging 6 th edition Surgery for stage IIIA NSCLC? Sometimes! Anne S. Tsao, M.D. Associate Professor Director, Mesothelioma Program Director, Thoracic Chemo-Radiation Program May 7, 2011 The University of Texas MD ANDERSON

More information

Thoracic Surgery; An Overview

Thoracic Surgery; An Overview Thoracic Surgery What we see Thoracic Surgery; An Overview James P. Locher, Jr, MD Methodist Cardiovascular and Thoracic Surgery Lung cancer Mets Fungus and TB Lung abcess and empyema Pleural based disease

More information

Tissue vs Mechanical What s the Data??

Tissue vs Mechanical What s the Data?? Biological (Tissue) Valve in a 60 year old patient: Debate Tissue vs Mechanical What s the Data?? Joseph E. Bavaria, MD Immediate-Past President - Society of Thoracic Surgeons (STS) Brooke Roberts-William

More information

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015

Breast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015 Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable

More information

Percutaneous aortic valve replacement should NOT be preferred therapy for aortic stenosis

Percutaneous aortic valve replacement should NOT be preferred therapy for aortic stenosis Percutaneous aortic valve replacement should NOT be preferred therapy for aortic stenosis James Bartholomew McClurken, MD FACC, FCCP, FACS, FESC Professor & Vice-Chair of Surgery, Temple University Hosp.,

More information